CGRP Inhibitors and Oxidative Stress Biomarkers in Resistant Migraine: A Real-Life Study with Erenumab, Fremanezumab, and Galcanezumab

Patients with high-frequency resistant migraine and medication-overuse headache are still the main clinical challenge in tertiary headache centers. The approval of targeted antibodies against the calcitonin gene-related peptide (CGRP) and its receptor represents a powerful instrument. In this study,...

Descripción completa

Detalles Bibliográficos
Autores principales: De Luca, Ciro, Baldacci, Filippo, Mazzucchi, Sonia, Lombardo, Irene, Curto, Letizia, Ulivi, Martina, Chico, Lucia, Papa, Michele, Siciliano, Gabriele, Gori, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509234/
https://www.ncbi.nlm.nih.gov/pubmed/34640604
http://dx.doi.org/10.3390/jcm10194586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509234/
https://www.ncbi.nlm.nih.gov/pubmed/34640604
http://dx.doi.org/10.3390/jcm10194586

Ejemplares similares